Identification of genes preferentially methylated in hepatitis C virus‐related hepatocellular carcinoma
Authors:
Open Access
- 19 May 2010
- journal article
- Published by Wiley in Cancer Science
- Vol. 101 (6) , 1501-1510
Abstract
Chronic infections by hepatitis B virus (HBV) and hepatitis C virus (HCV) appear to be the most significant causes of hepatocellular carcinoma (HCC). Aberrant promoter methylation is known to be deeply involved in cancer, including in HCC. In this study, we analyzed aberrant promoter methylation by methylated DNA immunoprecipitation‐on‐chip analysis on a genome‐wide scale in six HCCs including three HBV‐related and three HCV‐related HCCs, six matched noncancerous liver tissues, and three normal liver tissues. Candidate genes with promoter methylation were detected more frequently in HCV‐related HCC. Candidate genes methylated preferentially to HBV‐related or HCV‐related HCCs were detected and selected, and methylation levels of the selected genes were validated by quantitative methylation analysis using MALDI‐TOF mass spectrometry using 125 liver tissue samples, including 61 HCCs (28 HBV‐related HCCs and 33 HCV‐related HCCs) and 59 matched noncancerous livers, and five normal livers. Among analyzed genes, preferential methylation in HBV‐related HCC was validated in one gene only. However, 15 genes were found to be methylated preferentially in HCV‐related HCC, which was independent from age. Hierarchical clustering of HCC using these genes stratified HCV‐related HCC as a cluster of frequently methylated samples. The 15 genes included genes inhibitory to cancer‐related signaling such as RAS/RAF/ERK and Wnt/β‐catenin pathways. Methylation of dual specificity phosphatase 4 ( DUSP4 ), cytochrome P450, family 24, subfamily A, polypeptide 1 ( CYP24A1 ), and natriuretic peptide receptor A ( NPR1 ) significantly correlated with recurrence‐free survival. It was indicated that genes methylated preferentially in HCV‐related HCC exist, and that DNA methylation might play an important role in HCV‐related HCC by silencing cancer‐related pathway inhibitors, and might perhaps be useful as a prognostic marker. ( Cancer Sci 2010)Keywords
This publication has 45 references indexed in Scilit:
- Ras Promotes Growth by Alternative Splicing-Mediated Inactivation of the KLF6 Tumor Suppressor in Hepatocellular CarcinomaGastroenterology, 2008
- Epidermal Growth Factor Receptor and Protein Kinase C Signaling to ERK2Journal of Biological Chemistry, 2008
- Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinomaHepatology, 2008
- Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinomaJournal of Clinical Investigation, 2007
- The Epigenomics of CancerCell, 2007
- Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinomaCancer Letters, 2006
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinomaJournal of Hepatology, 2005
- Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-κBMolecular and Cellular Biology, 2003
- Significant Influence of Accompanying Chronic Hepatitis Status on Recurrence of Hepatocellular Carcinoma after HepatectomyAnnals of Surgery, 1996